Skeletal muscle bioenergetics in the chronic fatigue syndrome.
Barnes, P R, Taylor, D J, Kemp, G J et al. · Journal of neurology, neurosurgery, and psychiatry · 1993 · DOI
Quick Summary
Researchers used a special type of MRI scan to measure how muscles use energy in ME/CFS patients compared to healthy people. They found that most patients had normal muscle energy use, but about a quarter showed unusual patterns in how their muscles handled acid buildup during exercise. This suggests muscle metabolism problems may exist in some, but not all, ME/CFS patients.
Why It Matters
This study directly investigated whether muscle energy metabolism dysfunction explains ME/CFS fatigue, a central hypothesis in the field. The finding that most patients lack consistent metabolic abnormalities challenged oversimplified theories while identifying a potential metabolic subgroup, highlighting the importance of patient stratification in future research.
Observed Findings
Most ME/CFS patients (34 of 46) showed normal skeletal muscle bioenergetics on phosphorus MR spectroscopy
26% of patients (12 of 46) demonstrated abnormal pH-phosphocreatine relationships during exercise
6 patients showed excessive acidification relative to phosphocreatine depletion
6 patients showed reduced acidification relative to phosphocreatine depletion
No consistent group-level abnormalities in glycolysis, mitochondrial metabolism, or intracellular pH regulation
Inferred Conclusions
A specific, universal metabolic abnormality does not underlie fatigue in ME/CFS as a whole
Metabolic dysfunction may be present in a minority subgroup of ME/CFS patients requiring further characterization
Skeletal muscle bioenergetics abnormalities are not a necessary feature of ME/CFS pathophysiology
Remaining Questions
What distinguishes the 26% of patients with abnormal pH-phosphocreatine relationships clinically or biochemically?
Could metabolic abnormalities exist in tissues beyond skeletal muscle (mitochondria, brain, other organs)?
What This Study Does Not Prove
This study does not prove that ME/CFS has no metabolic basis—it only shows no universal pattern across the group. It does not establish causation or explain fatigue mechanisms in the 74% of patients with normal muscle metabolism. Small sample size and cross-sectional design limit generalizability and cannot reveal disease mechanisms.
Tags
Symptom:Fatigue
Biomarker:Metabolomics
Method Flag:Weak Case DefinitionSmall SampleExploratory Only